356 related articles for article (PubMed ID: 17012445)
21. Outcome of fetuses with enlarged nuchal translucency and normal karyotype.
Bilardo CM; Pajkrt E; de Graaf I; Mol BW; Bleker OP
Ultrasound Obstet Gynecol; 1998 Jun; 11(6):401-6. PubMed ID: 9674085
[TBL] [Abstract][Full Text] [Related]
22. Do early pregnancy ultrasound measurements correlate with fetal nuchal translucency at 11-14 weeks?
Prefumo F; Condous G; Papageorghiou A; Thilaganathan B; Bourne T
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):628-31. PubMed ID: 16514621
[TBL] [Abstract][Full Text] [Related]
23. Increased nuchal translucency as a marker for fetal chromosomal defects.
Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
[TBL] [Abstract][Full Text] [Related]
24. The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks.
Schaefer M; Laurichesse-Delmas H; Ville Y
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):271-3. PubMed ID: 9618851
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic value of a detailed first trimester anomaly scan in fetuses with increased nuchal translucency thickness.
Tekesin I
J Perinat Med; 2019 Feb; 47(2):241-246. PubMed ID: 30218607
[TBL] [Abstract][Full Text] [Related]
26. First-trimester fetuses with increased nuchal translucency do not show altered intracardiac flow velocities.
Haak MC; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):246-52. PubMed ID: 15719441
[TBL] [Abstract][Full Text] [Related]
27. [Outcome of fetuses with malformations discovered before 14 weeks. Where the discovery is revealed by echography during the first trimester, is it responsible for the voluntary termination of the pregnancy? Comparison before and after July 2001].
Mangione R; Fries N; Godard P; Fontanges M; Haddad G; Mirlesse V;
J Gynecol Obstet Biol Reprod (Paris); 2008 Apr; 37(2):154-62. PubMed ID: 18036748
[TBL] [Abstract][Full Text] [Related]
28. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
[TBL] [Abstract][Full Text] [Related]
29. Abnormal Shh and FOXC2 expression correlates with aberrant lymphatic development in human fetuses with increased nuchal translucency.
de Mooij YM; van den Akker NM; Bekker MN; Bartelings MM; Wisse LJ; van Vugt JM; Gittenberger-de Groot AC
Prenat Diagn; 2009 Sep; 29(9):840-6. PubMed ID: 19548265
[TBL] [Abstract][Full Text] [Related]
30. Disappearance of enlarged nuchal translucency before 14 weeks' gestation: relationship with chromosomal abnormalities and pregnancy outcome.
Müller MA; Pajkrt E; Bleker OP; Bonsel GJ; Bilardo CM
Ultrasound Obstet Gynecol; 2004 Aug; 24(2):169-74. PubMed ID: 15287055
[TBL] [Abstract][Full Text] [Related]
31. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
[TBL] [Abstract][Full Text] [Related]
32. Nuchal translucency thickness and outcome in chromosome translocation diagnosed in the first trimester.
Sepulveda W; Be C; Youlton R; Carstens E; Reyes M
Prenat Diagn; 2001 Sep; 21(9):726-8. PubMed ID: 11559907
[TBL] [Abstract][Full Text] [Related]
33. Jugular vein and carotid artery blood flow in fetuses with increased nuchal translucency at 10-14 weeks' gestation.
Martínez JM; Echevarría M; Gómez O; Del Río M; Borrell A; Puerto B; Fortuny A
Ultrasound Obstet Gynecol; 2003 Nov; 22(5):464-9. PubMed ID: 14618658
[TBL] [Abstract][Full Text] [Related]
34. Association between increased nuchal translucency and second trimester cardiac echogenic foci.
Prefumo F; Presti F; Thilaganathan B; Carvalho JS
Obstet Gynecol; 2003 May; 101(5 Pt 1):899-904. PubMed ID: 12738147
[TBL] [Abstract][Full Text] [Related]
35. The influence of fetal position on nuchal translucency thickness.
de Graaf IM; Müller MA; van Zuylen-Vié AA; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 2000 Jun; 15(6):520-2. PubMed ID: 11005121
[TBL] [Abstract][Full Text] [Related]
36. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
[TBL] [Abstract][Full Text] [Related]
37. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
Josefsson A; Molander E; Selbing A
Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
[TBL] [Abstract][Full Text] [Related]
38. Nuchal translucency measurement in normal fetuses.
Pajkrt E; Bilardo CM; Van Lith JM; Mol BW; Bleker OP
Obstet Gynecol; 1995 Dec; 86(6):994-7. PubMed ID: 7501355
[TBL] [Abstract][Full Text] [Related]
39. Nuchal translucency in normal fetuses in a Thai population.
Panburana P; Jaovisidh A; Ajjimakorn S; Tungkajiwangoon P
J Med Assoc Thai; 2002 Feb; 85(2):245-9. PubMed ID: 12081126
[TBL] [Abstract][Full Text] [Related]
40. First trimester nuchal translucency: effective routine screening for Down's syndrome.
Thilaganathan B; Sairam S; Michailidis G; Wathen NC
Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
